Trial Profile
Phase II study of antineoplastons A10 [antineoplaston-A10] and AS2-1 [antineoplaston-AS2-1] capsules in patients with adenocarcinoma of the colon
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 12 Dec 2006 Status change
- 09 Aug 2005 New trial record.